Concepedia

David A. Alagpulinsa

DA

6

Publications

396

Citations

6

H-Index

2014

Active since

Affiliations

Central Arkansas Veterans Healthcare System(Current)

Harvard University

Massachusetts General Hospital

University of Arkansas for Medical Sciences

David A. Alagpulinsa is an author at Central Arkansas Veterans Healthcare System specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2014–2020

6

Publications

6

A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin

David A. Alagpulinsa, Srinivas Ayyadevara, Robert Joseph Shmookler Reis · Frontiers in Oncology · 2014 · 126 citations · Full text

Alginate-microencapsulation of human stem cell–derived β cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression

David A. Alagpulinsa, Jenny J.L. Cao, Riley K. Driscoll et al. · American Journal of Transplantation · 2019 · 125 citations · Full text

A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition

David A. Alagpulinsa, Srinivas Ayyadevara, Shmuel Yaccoby et al. · Molecular Cancer Therapeutics · 2015 · 70 citations · Full text

, , +20

A peptide nucleic acid targeting nuclear<i>RAD51</i>sensitizes multiple myeloma cells to melphalan treatment

David A. Alagpulinsa, Shmuel Yaccoby, Srinivas Ayyadevara et al. · Cancer Biology & Therapy · 2015 · 35 citations · Full text

, , +12

Metabolomic and transcriptomic analyses of the anti-rheumatoid arthritis potential of xylopic acid in a bioinspired lipoprotein nanoformulation

Raphael N. Alolga, Yaw Opoku‐Damoah, David A. Alagpulinsa et al. · Biomaterials · 2020 · 22 citations

, , +13

Rows per page

1–5 of 6